PMC · DOI:10.1007/s11897-023-00639-5·December 1, 2023
Correction to: Differentiating Cardiac Troponin Levels During Cardiac Myosin Inhibition or Cardiac Myosin Activation Treatments: Drug Effect or the Canary in the Coal Mine?
Matthew M. Y. Lee, Ahmad Masri
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Diseases1
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAcute Myocardial Infarction Research · Lipoproteins and Cardiovascular Health · Cardiac Imaging and Diagnostics
Full text
Correction to **: ** Curr Heart Fail Rep. 2023
https://doi.org/10.1007/s11897-023-00620-2
- Figure 2 has been updated with corrected numbers.
- Online version references 78-88 have been corrected (as per PDF).
- The title of Table 1, Table 3, and Table 4 had references [87], [88], and [88], respectively. These references were added in error during the proof corrections stage and have now been removed.
- Added abbreviation PK pharmacokinetics to Table 3 footnote.
- Removed OM in title of Table 4.
The original version has been corrected.